To study GM3(Neu5Gc)-targeting CAR-T cells in vivo, we employed engineered SKOV3 tumor cells expressing the CMAH enzyme, which restores Neu5Gc biosynthesis and GM3(Neu5Gc) presentation (15). Here, CMAHP is linked to neoplasm.